-
Je něco špatně v tomto záznamu ?
Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells
Petra Faltejskova, Andrej Besse, Sabina Sevcikova, Lenka Kubiczkova, Marek Svoboda, Jan Smarda, Igor Kiss, Rostislav Vyzula, Ondrej Slaby
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS9814
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ProQuest Central
od 1997-03-01 do 2018-12-31
Medline Complete (EBSCOhost)
od 2000-02-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-03-01 do 2018-12-31
Springer Nature OA/Free Journals
od 1986-03-01
- MeSH
- antitumorózní látky farmakologie terapeutické užití MeSH
- apoptóza účinky léků genetika MeSH
- buněčný cyklus účinky léků genetika MeSH
- Kaplanův-Meierův odhad MeSH
- kolorektální nádory farmakoterapie genetika patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikro RNA antagonisté a inhibitory genetika metabolismus MeSH
- nádorové buněčné linie MeSH
- nádory tračníku genetika patologie MeSH
- pohyb buněk účinky léků genetika MeSH
- regulace genové exprese u nádorů účinky léků MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- viabilita buněk účinky léků genetika MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
PURPOSE: MicroRNA-21 (miR-21) is one of the miRNAs that are frequently and highly overexpressed in tumor tissue of colorectal cancer (CRC) patients; however, only a little is known about its functional role in CRC. METHODS: We examined the expression level of miR-21 in 44 paired samples of tumoral and non-tumoral colon tissues diagnosed for CRC using TaqMan real-time PCR method. Furthermore, we used miR-21 inhibitor (anti-miR-21) to transient knockdown of miR-21 in DLD-1 colon cancer cells and examined the effects of miR-21 silencing on viability, apoptosis, chemosensitivity, cell cycle, and migration of DLD1 cells. RESULTS: The expression levels of miR-21 were significantly increased in CRC tumor tissue (P < 0.0001). Significant differences in miR-21 levels were observed also between CRC tissues of patients with CRC in different clinical stages: I vs. II (P = 0.033) and I vs. IV (P = 0.021). Kaplan-Meier analysis proved that the miR-21 expression levels are correlated to shorter overall survival of CRC patients (P = 0.0341). MiR-21 silencing in DLD1 cell line had no effect on the cell viability; however, when combined with chemotherapeutics (5-FU, L-OHP, and SN38), it contributed to the decrease of cell viability. Suppression of miR-21 decreased cell migration ability of DLD-1 cells by nearly 30 % (P = 0.016). CONCLUSION: We have confirmed the overexpression of miR-21 in CRC samples and its correlation with advanced disease and shorter overall survival. These findings could be described in part by the fact that CRC cells with increased expression of miR-21 have higher migration ability.
Central European Institute of Technology Masaryk University Brno Czech Republic
Department of Comprehensive Cancer Care Masaryk Memorial Cancer Institute Brno Czech Republic
Department of Experimental Biology Faculty of Science Masaryk University Brno Czech Republic
Department of Pathological Physiology Faculty of Medicine Masaryk University Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13012720
- 003
- CZ-PrNML
- 005
- 20170411113830.0
- 007
- ta
- 008
- 130404s2012 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00384-012-1461-3 $2 doi
- 035 __
- $a (PubMed)22476768
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Faltejskova, Petra $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 245 10
- $a Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells / $c Petra Faltejskova, Andrej Besse, Sabina Sevcikova, Lenka Kubiczkova, Marek Svoboda, Jan Smarda, Igor Kiss, Rostislav Vyzula, Ondrej Slaby
- 520 9_
- $a PURPOSE: MicroRNA-21 (miR-21) is one of the miRNAs that are frequently and highly overexpressed in tumor tissue of colorectal cancer (CRC) patients; however, only a little is known about its functional role in CRC. METHODS: We examined the expression level of miR-21 in 44 paired samples of tumoral and non-tumoral colon tissues diagnosed for CRC using TaqMan real-time PCR method. Furthermore, we used miR-21 inhibitor (anti-miR-21) to transient knockdown of miR-21 in DLD-1 colon cancer cells and examined the effects of miR-21 silencing on viability, apoptosis, chemosensitivity, cell cycle, and migration of DLD1 cells. RESULTS: The expression levels of miR-21 were significantly increased in CRC tumor tissue (P < 0.0001). Significant differences in miR-21 levels were observed also between CRC tissues of patients with CRC in different clinical stages: I vs. II (P = 0.033) and I vs. IV (P = 0.021). Kaplan-Meier analysis proved that the miR-21 expression levels are correlated to shorter overall survival of CRC patients (P = 0.0341). MiR-21 silencing in DLD1 cell line had no effect on the cell viability; however, when combined with chemotherapeutics (5-FU, L-OHP, and SN38), it contributed to the decrease of cell viability. Suppression of miR-21 decreased cell migration ability of DLD-1 cells by nearly 30 % (P = 0.016). CONCLUSION: We have confirmed the overexpression of miR-21 in CRC samples and its correlation with advanced disease and shorter overall survival. These findings could be described in part by the fact that CRC cells with increased expression of miR-21 have higher migration ability.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a antitumorózní látky $x farmakologie $x terapeutické užití $7 D000970
- 650 _2
- $a apoptóza $x účinky léků $x genetika $7 D017209
- 650 _2
- $a buněčný cyklus $x účinky léků $x genetika $7 D002453
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a pohyb buněk $x účinky léků $x genetika $7 D002465
- 650 _2
- $a viabilita buněk $x účinky léků $x genetika $7 D002470
- 650 _2
- $a nádory tračníku $x genetika $x patologie $7 D003110
- 650 _2
- $a kolorektální nádory $x farmakoterapie $x genetika $x patologie $7 D015179
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a regulace genové exprese u nádorů $x účinky léků $7 D015972
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Kaplanův-Meierův odhad $7 D053208
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mikro RNA $x antagonisté a inhibitory $x genetika $x metabolismus $7 D035683
- 650 _2
- $a lidé středního věku $7 D008875
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Besse, Andrej $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 700 1_
- $a Sevcikova, Sabina $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Kubiczkova, Lenka $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Svoboda, Marek $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 700 1_
- $a Smarda, Jan $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Kiss, Igor $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 700 1_
- $a Vyzula, Rostislav $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 700 1_
- $a Slaby, Ondrej $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 773 0_
- $w MED00002307 $t International journal of colorectal disease $x 1432-1262 $g Roč. 27, č. 11 (2012), s. 1401-1408
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22476768 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130404 $b ABA008
- 991 __
- $a 20170411114129 $b ABA008
- 999 __
- $a ok $b bmc $g 975918 $s 811001
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 27 $c 11 $d 1401-1408 $i 1432-1262 $m International journal of colorectal disease $n Int J Colorectal Dis $x MED00002307
- GRA __
- $a NS9814 $p MZ0
- LZP __
- $a Pubmed-20130404